Denosumab-induced Acute Generalized Exanthematous Pustulosis
DOI:
https://doi.org/10.2340/actadv.v104.40430Keywords:
Adverse drug reaction, psoriasisAbstract
Abstract is missing (Short communication)
Downloads
References
Stadler PC, Oschmann A, Kerl-French K, Maul JT, Oppel EM, Meier-Schiesser B, et al. Acute generalized exanthematous pustulosis: clinical characteristics, pathogenesis, and management. Dermatology 2023; 239: 328-333.
https://doi.org/10.1159/000529218 DOI: https://doi.org/10.1159/000529218
Sussman M, Napodano A, Huang S, Are A, Hsu S, Motaparthi. Pustular psoriasis and acute generalized exanthematous pustulosis. Medicina (Kaunas) 2021; 57: 1004.
https://doi.org/10.3390/medicina57101004 DOI: https://doi.org/10.3390/medicina57101004
Bautista-Villanueva S, Galleani C, Barranco R, Bellón T, Blanco M, García-Moguel I. Acute localized exanthematous pustulosis due to alendronate. J Investig Allergol Clin Immunol 2021; 32: 69-70.
https://doi.org/10.18176/jiaci.0709 DOI: https://doi.org/10.18176/jiaci.0709
Bachelez H, Barker J, Burden AD, Navarini AA, Krueger JG. Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion. Expert Rev Clin Immunol 2022; 18: 1033-1047.
https://doi.org/10.1080/1744666X.2022.2116003 DOI: https://doi.org/10.1080/1744666X.2022.2116003
Kodali N, Blanchard I, Kunamneni S, Lebwohl MG. Current management of generalized pustular psoriasis. Exp Dermatol 2023; 32: 1204-1218.
https://doi.org/10.1111/exd.14765 DOI: https://doi.org/10.1111/exd.14765
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Maruška Marovt, Pij B. Marko
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
